SecBot SecBot
6-K ·Filed Nov 12, 2026

ASND

Ascendis Pharma A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 7h ago SEC0001193125-26-458255
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine employee incentive grant with negligible dilution. No trading signal. Monitor upcoming quarterly results for revenue and pipeline progress.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$275.39
T+0 close · Nov 12, 2026 · via day close
Latest settled
−1.33%
T+1 · $271.73
Vs SPY
+0.58%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $275.39entry
  2. T+1 · 16h ago −1.33%α +0.58% · $271.73
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Ascendis Pharma filed its updated Articles of Association and disclosed a routine grant of 28,030 employee warrants at $256.59 per share. The filing is a governance update with no financial results or material business events.

Key Facts

  • Board granted 28,030 warrants to employees on November 10, 2026 at $256.59 per share
  • Warrants vest 25% after one year, then 1/36th monthly for remaining 75%
  • After grant, 1,431,143 warrants remain available for future grant
  • Articles of Association updated to reflect the grant and other historical warrant activity
  • No financial results, guidance, or material corporate events reported

Financial Impact

28,030 warrants represent approximately 0.04% of outstanding shares (based on DKK 66.4M share capital at DKK 1 per share); minimal dilution

dilution

Risk Factors

  • None from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
96% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001193125-26-458255
Document: d179714d6k.htm0001193125-26-458255
Document: 0001193125-26-458255-index-headers.html0001193125-26-458255
Document: 0001193125-26-458255-index.html0001193125-26-458255
Document: 0001193125-26-458255.txt0001193125-26-458255
Earnings Context (Synthetic; results releases only)0001193125-26-458255

Track record

41 reports on ASND

Performance horizon

14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
  2. Nov 12, 20264d ago 6-K Neutral 2/10 Viewing Entry $275.39 Now $271.73 −1.33% settles Feb 11
  3. Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
  4. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
  5. Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
  6. Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
  7. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.73 +7.21% settles Feb 3
  8. Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
  9. Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
  10. Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
Showing 10 of 41

US Market Status

Market Closed · Opens Wed (10h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026